- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01843907
Patient Participation in Prevention of Loss of Functions
Cross-sectorial Patient Participation in Prevention of Loss of Functions in Older Short-stay Medical Patients
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
At baseline:
Nutritional status, BMI and weight, depression (GDS5), dementia (MMSE), pain (Verbal Ranking Scale), muscle strength (hand-grip strength, chair-to-stand-test), quality of life (EQ5D), coping (Sense of Coherence 13 item scale), patient experience (NORPEQ), medication management (MedMaide).
At follow-up three months after discharge:
BMI and weight, depression (GDS5), dementia (MMSE), pain (Verbal Ranking Scale), muscle strength (hand-grip strength, chair-to-stand-test) and EQ5D. In addition, need for initiated municipal assistance after discharge. Project employee who performs data collection is blinded to the group to which the patient is randomized.
The control group Patients in the control group undergo the same measurements and registrations at discharge and 3 - month follow-up, as the intervention groups, but receive otherwise usual treatment and care, and are discharged without further intervention. After six months control patients receive a report comprising the screening results, relevant information material and a cover letter. Patients' GP and municipality care section receive a summary of outcomes, as well as a cover letter.
Register data Information on mortality, readmissions and services in primary health care are obtained after 6 months from the National Patient Register, Population Register and municipalities.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Herlev, Denmark, 2730
- Herlev Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 65 years or older
- Living in their own home with no contact to the Municipality, both before and after admission
- Discharged from Department o105 or the Acute Receiving Unit <48 hours from admission.
Exclusion Criteria:
- Patients with life-threatening disease in the terminal stage
- Patients who does not speak and understand Danish
- Patients who are not able to communicate and collaborate, with regards to the measurements
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Empowerment
Patients in the intervention group 1 receive a communication report which will also be sent to the physician and home care.
In communication report includes the results and interpretation and explanation of the measurements in layman's terms.
The report also includes relevant and targeted information on pain management, depression among the elderly, dementia and disability in old age and ways to maintain and improve functional capacity.
Links and addresses of relevant, local organizations, and networks are also included.
The information material is also included in the report sent to the General Practitioner (GP) and home care.
|
To give patients the necessary resources to take care of their own health
|
|
Other: Conversation with Nurse
Patients in the intervention group 2 gets clarification and follow-up conversation with a nurse anchored in both medical department and municipalities.
The nurse is "blinded" in relation to the patient's screening results.
Problems identified in connection therewith are communicated to the GP and home care.
|
To find out, if the nurse, using her ....
|
|
No Intervention: Controle Group
Patients in the control group are undergoing the same measurements and records at discharge, as the intervention group, but are otherwise receiving treatment and care as usual without further intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participants who have been readmitted to hospital
Time Frame: 01.03.2013 - 12.31.2014
|
Number of participants who have been readmitted to hospital.
Measured 6 months after admission.
|
01.03.2013 - 12.31.2014
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mortality
Time Frame: 01.04.2014 - 31.12.2014
|
Mortality.
Number of participants, who have died.
Measured 6 months after admission.
|
01.04.2014 - 31.12.2014
|
|
Functional ability
Time Frame: 31.12.2014
|
Measured 3 months after discharge. Functional ability Handgrip-strength 4 second test: Hand- and forearm muscular strength in kg. and 30 second chair stand test: Lower-body muscle strength |
31.12.2014
|
|
Primary Healthcare Services
Time Frame: 01.04.2013 - 31.12.2014
|
Delivered services in Primary Healthcare.
Measured 6 months after admission.
|
01.04.2013 - 31.12.2014
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Tove L. Damsgaard, Herlev Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-1-2012-118
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.